- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01201226
Can Dormant Perimenopausal Ovarian Follicles Become FSH Responsive?
Can Dormant Ovarian Follicles From Perimenopausal Women Become Gonadotropin Responsive by Incubation With PTEN Inhibitor and PI3K Activating Peptide?
Study Overview
Status
Intervention / Treatment
Detailed Description
Introduction Women stop menstruating at the mean age of 51, yet pregnancies become much less prevalent beyond 40, with pregnancy at 43 being a relative rarity. Current common perception attributes the regression of fertility to depletion of the primordial follicles' pool (Burger et al. 2008). The decline in fertility may result not necessarily from a sharp depletion of the primordial follicle pool (Hansen et al. 2008) but may be due to failure of adequate transition from primordial to antral, gonadotropin-responsive follicles. It is not infrequent to encounter a fertility patient at her late thirties or early forties, who would not respond to the most extreme doses of exogenous FSH, but will nevertheless continue to menstruate until the age of 50. The usual practice is to refer these patients to oocyte donation programs.
Recently, Li et al. (2010) demonstrated that incubation of neonatal mouse ovarian fragments with an inhibitor of the Phosphatase with TENsin homology deleted in chromosome 10 (PTEN) phosphatase and a PI3K activating peptide, increased nuclear exclusion of Foxo3 and propelled large numbers of dormant primordial follicles into becoming FSH-responsive antral follicles. Furthermore, in the nude mice model (mice lacking immune system) they showed that transplanted human ovarian fragments containing mainly primordial follicles from surgical specimens, treated by the same incubation, also underwent activation of dormant follicles to derive preovulatory follicles containing mature oocytes.
Based on all the above we hypothesize, that ovaries of women at their perimenopausal years could be propelled to become FSH-responsive, using incubation with PTEN inhibitor and PI3K activating peptide to activate dormant primordial follicles.
If found feasible, this technique could provide hope of achieving fertility to patients who would otherwise be referred to receive oocyte donation.
Aim of the proposed study To obtain ovarian cortical fragments from perimenopausal patients, who undergo gynecological surgery, and test whether treatment with PTEN phosphatase and PI3K activating peptide would induce these fragments to produce FSH responsive follicles in the nude mouse model.
Study subjects and specimen harvest Up to ten women, older than 45 years, who are scheduled to gynecological operation, will be asked to provide half of an ovary for the study. The tissue will then be cut to multiple fragments, suitable for cryopreservation.
Laboratory methods Cryopreservation of ovarian fragments will use a vitrification protocol similar to earlier report for oocyte cryo-storage (Yoon et al. 2003). Because the cryo-preservation reagents can easily penetrate primordial follicles as compared with the large oocytes, we anticipate efficient preservation of these follicles. In young patients, one 1 mm cortical cubes contains ~50 primordial follicles.
Three tissue samples from each patient will be transferred to the Hsueh laboratory in Stanford (attached letter), and will be thawed for in vitro activation followed by xeno-transplantation using the same protocol as that described by Li et al. from that laboratory. (Li et al. 2010). The in vitro incubation will be in bpV(pic) (Calbiochem), a PTEN inhibitor, which allows the activation of dormant follicles. and a cell-permeable phospho-peptide (740Y-P) (Tocris) capable of binding to the SH2 domain of the p85 regulatory subunit of PI3K to stimulate enzyme activity. Activated PI3K converts phosphatidylinositol (4, 5)-bisphosphate (PIP2) to phosphatidylinositol (3-5)-trisphosphate (PIP3), whereas the PTEN inhibitor prevents the conversion of PIP3 back to PIP2. Accumulated PIP3, in turn, could stimulate the phosphorylation of Akt and increase the nuclear exclusion of the transcriptional factor Foxo3.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Izhar Ben-Shlomo, MD
- Phone Number: 972-52-6124781
- Email: ibenshlomo@poria.health.gov.il
Study Contact Backup
- Name: Moshe Ben-Smi, MD
- Email: mbenami@poria.health.gov.il
Study Locations
-
-
-
Tiberias, Israel, 15208
- Department of Obstetrics and Gynecology, Baruch Padeh Medical Center, Poria
-
Principal Investigator:
- Izhar Ben-Shlomo, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women older than 45 years, undergoing pelvic organ surgery
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Patients
Perimenopausal women, who will undergo oelvic organ surgery, and will allow harvest of about half an oary for the study purpose
|
Removal of half an ovary
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ability of primordial follicles to respond to FSH after incubation
Time Frame: Two weeks
|
Human ovarian fragments will be incubated with PTEN inhibitor and PI3K activating peptide and will then be transplanted to nude mice.
Subsequently mice will recieve FSH, and follicular response will be monitored.
|
Two weeks
|
Collaborators and Investigators
Investigators
- Study Chair: Izhar Ben-Shlomo, MD, Dept. Ob/Gyn, Baruch Padeh Medical Center, Poria, Israel
Publications and helpful links
General Publications
- Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod. 2008 Mar;23(3):699-708. doi: 10.1093/humrep/dem408. Epub 2008 Jan 11.
- Li J, Kawamura K, Cheng Y, Liu S, Klein C, Liu S, Duan EK, Hsueh AJ. Activation of dormant ovarian follicles to generate mature eggs. Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10280-4. doi: 10.1073/pnas.1001198107. Epub 2010 May 17.
- Yoon TK, Kim TJ, Park SE, Hong SW, Ko JJ, Chung HM, Cha KY. Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transfer program. Fertil Steril. 2003 Jun;79(6):1323-6. doi: 10.1016/s0015-0282(03)00258-9.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PrimordialFollicleActivat.CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low Ovarian Reserve
-
IVI BilbaoRecruiting
-
Sun Yat-sen UniversityUnknown
-
Guangzhou First People's HospitalUnknownLow Ovarian Reserve | GH
-
Hadassah Medical OrganizationWithdrawnLow Ovarian Reserve | Poor Quality OocytesIsrael
-
Center for Human ReproductionRecruitingDiminished Ovarian Reserve | Ovarian FailureUnited States
-
Generation Next FertilityIgenomixNot yet recruitingDiminished Ovarian Reserve
-
Beni-Suef UniversityRecruiting
-
Huazhong University of Science and TechnologyRecruitingDecreased Ovarian ReserveChina
-
American University of Beirut Medical CenterCompleted
-
Lucy ColemanCompletedOvarian ReserveVenezuela
Clinical Trials on Removal of half an ovary
-
University of TennesseeCompletedSecondary Infertility | Endocrine Disorders of Female Reproductive System | Infertility InvoluntaryUnited States
-
Weill Medical College of Cornell UniversityRecruitingCancer | Fertility Preservation | Risk of Premature Ovarian FailureUnited States
-
Maastricht University Medical CenterUnknownDiabetes Mellitus Type 2 | Pressure Ulcer | Charcot- Osteoarthropathy
-
University of AarhusRecruitingFertility Disorders | Turner Syndrome | Premature Ovarian FailureDenmark
-
NYU Langone HealthCompletedAtrial FibrillationUnited States
-
Hospital Universitario La FeWithdrawn
-
Vanderbilt UniversityUnited States Surgical CorporationCompletedObesity | Dyslipidemia | Hypercholesterolemia | Diabetes Mellitus Type 2United States
-
Liverpool University Hospitals NHS Foundation TrustCompleted
-
Navamindradhiraj UniversityActive, not recruitingRemoval of Fibrosynovial Tissue | Non-removal of Fibrosynovial Tissue | Patellar Non-resurfacingThailand
-
Assiut UniversityNot yet recruitingCesarean Wound; Dehiscence